Literature DB >> 12073012

A loss-of-function mutation in the CFC domain of TDGF1 is associated with human forebrain defects.

June M de la Cruz1, Richard N Bamford, Rebecca D Burdine, Erich Roessler, A James Barkovich, Dian Donnai, Alexander F Schier, Maximilian Muenke.   

Abstract

TDGF1 (CRIPTO) is an EGF-CFC family member and an obligate co-receptor involved in NODAL signaling, a developmental program implicated in midline, forebrain, and left-right axis development in model organisms. Previous studies of CFC1 (CRYPTIC), another member of the EGF-CFC family, demonstrated that normal function of this protein is required for proper laterality development in humans. Here we identify a mutation in the conserved CFC domain of TDGF1 in a patient with midline anomalies of the forebrain. The mutant protein is inactive in a zebrafish rescue assay, indicating a role for TDGF1 in human midline and forebrain development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12073012     DOI: 10.1007/s00439-002-0709-3

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  28 in total

Review 1.  Nodal morphogens.

Authors:  Alexander F Schier
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-11       Impact factor: 10.005

2.  Genetic and Molecular Analyses indicate independent effects of TGIFs on Nodal and Gli3 in neural tube patterning.

Authors:  Kenichiro Taniguchi; Anoush E Anderson; Tiffany A Melhuish; Anne L Carlton; Arkadi Manukyan; Ann E Sutherland; David Wotton
Journal:  Eur J Hum Genet       Date:  2016-12-07       Impact factor: 4.246

3.  NOTCH, a new signaling pathway implicated in holoprosencephaly.

Authors:  Valérie Dupé; Lucie Rochard; Sandra Mercier; Yann Le Pétillon; Isabelle Gicquel; Claude Bendavid; Georges Bourrouillou; Usha Kini; Christel Thauvin-Robinet; Timothy P Bohan; Sylvie Odent; Christèle Dubourg; Véronique David
Journal:  Hum Mol Genet       Date:  2010-12-31       Impact factor: 6.150

4.  SONIC HEDGEHOG mutations causing human holoprosencephaly impair neural patterning activity.

Authors:  Can Schell-Apacik; Mariel Rivero; Jessica L Knepper; Erich Roessler; Maximilian Muenke; Jeffrey E Ming
Journal:  Hum Genet       Date:  2003-04-23       Impact factor: 4.132

Review 5.  Functional analysis of mutations in TGIF associated with holoprosencephaly.

Authors:  Kenia B El-Jaick; Shannon E Powers; Laurent Bartholin; Kenneth R Myers; Jin Hahn; Ieda M Orioli; Maia Ouspenskaia; Felicitas Lacbawan; Erich Roessler; David Wotton; Maximilian Muenke
Journal:  Mol Genet Metab       Date:  2006-09-07       Impact factor: 4.797

6.  Transforming growth-interacting factor (TGIF) regulates proliferation and differentiation of human myeloid leukemia cells.

Authors:  Rizwan Hamid; Stephen J Brandt
Journal:  Mol Oncol       Date:  2009-07-29       Impact factor: 6.603

7.  Loss-of-function mutations in growth differentiation factor-1 (GDF1) are associated with congenital heart defects in humans.

Authors:  J D Karkera; J S Lee; E Roessler; S Banerjee-Basu; M V Ouspenskaia; J Mez; E Goldmuntz; P Bowers; J Towbin; J W Belmont; A D Baxevanis; A F Schier; M Muenke
Journal:  Am J Hum Genet       Date:  2007-09-28       Impact factor: 11.025

Review 8.  Extracephalic manifestations of nonchromosomal, nonsyndromic holoprosencephaly.

Authors:  Ariel F Martinez; Paul S Kruszka; Maximilian Muenke
Journal:  Am J Med Genet C Semin Med Genet       Date:  2018-05-15       Impact factor: 3.908

9.  Reduced NODAL signaling strength via mutation of several pathway members including FOXH1 is linked to human heart defects and holoprosencephaly.

Authors:  Erich Roessler; Maia V Ouspenskaia; Jayaprakash D Karkera; Jorge I Vélez; Amy Kantipong; Felicitas Lacbawan; Peter Bowers; John W Belmont; Jeffrey A Towbin; Elizabeth Goldmuntz; Benjamin Feldman; Maximilian Muenke
Journal:  Am J Hum Genet       Date:  2008-06-05       Impact factor: 11.025

10.  Spectrum of holoprosencephaly.

Authors:  Seema Thakur; Renu Singh; M Pradhan; Shubha R Phadke
Journal:  Indian J Pediatr       Date:  2004-07       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.